ArkeaBio is a pioneering agricultural biotechnology company focused on developing innovative vaccines to reduce methane emissions from cows and enhance ruminal health. Operating within the clean technology sector, ArkeaBio serves the agricultural industry, particularly livestock farmers and dairy producers. The company leverages advanced biotechnological research to adapt its vaccine targets, ensuring they remain effective against the evolving ruminal microbiome influenced by regional, feed, and seasonal variations. ArkeaBio's business model revolves around the development and commercialization of these vaccines, generating revenue through product sales and potentially through government grants and subsidies aimed at reducing environmental impact. The company has received significant funding from the Government of Alberta, highlighting its role in the Emissions Reduction Alberta Emerging Innovators Challenge. By continuously validating the benefits of its products through extensive data collection and analysis, ArkeaBio aims to provide measurable improvements in animal health and environmental sustainability.

Keywords: agricultural biotechnology, methane reduction, cow vaccines, ruminal health, livestock farming, dairy industry, clean technology, bioproducts, environmental sustainability, Alberta funding.